Detailed answers about AVERROES PHARMACY (BRADFORD) LIMITED, including incorporation, status, business activity, and accounts information.
When was AVERROES PHARMACY (BRADFORD) LIMITED founded?
AVERROES PHARMACY (BRADFORD) LIMITED was officially incorporated on 14 February 2011 and is registered under company number 07528866. Incorporation establishes the company as a legal entity registered at Companies House, allowing it to trade, enter contracts, and operate under UK company law.
What type of company is AVERROES PHARMACY (BRADFORD) LIMITED?
Private Limited Company. This classification indicates the legal structure of the company, which determines the way it is governed, its liability, and regulatory obligations. A private limited company (Ltd) limits the personal liability of its shareholders.
What is the current status of AVERROES PHARMACY (BRADFORD) LIMITED?
AVERROES PHARMACY (BRADFORD) LIMITED's current status is Active. The company status indicates whether it is actively trading, dormant, or has been dissolved. Maintaining an active status is essential for legally conducting business, filing accounts, and maintaining credibility with partners and lenders.
What does AVERROES PHARMACY (BRADFORD) LIMITED do?
AVERROES PHARMACY (BRADFORD) LIMITED operates in the following sector: 47749 - Retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c.. This provides insight into the company's primary business activity and industry focus.
What is AVERROES PHARMACY (BRADFORD) LIMITED's registered address?
The registered office address of AVERROES PHARMACY (BRADFORD) LIMITED is TRUST HOUSE C/O ISAACS, ST JAMES BUSINESS PARK, 5 NEW AUGUSTUS STREET, BRADFORD, WEST YORKSHIRE, ENGLAND, BD1 5LL. This is the official address filed with Companies House for legal and statutory correspondence.
Is AVERROES PHARMACY (BRADFORD) LIMITED financially stable?
The most recent accounts for AVERROES PHARMACY (BRADFORD) LIMITED were made up to 28 February 2025, filed as DORMANT. Next accounts are due by 30 November 2026.